Resverlogix Announces Lifting by TSX of Review
|
5
|
Resverlogix Corp.
|
May 10, 2018 09:15AM
|
Re: Almost 1.25 years now
|
5
|
Zenith Epigenetics
|
May 31, 2018 06:48AM
|
Interesting paper on BET inhibitors and Memory
|
5
|
Resverlogix Corp.
|
Jan 27, 2019 06:03PM
|
Re: You're right 10bagr, you didn't sway me....
|
5
|
Resverlogix Corp.
|
Feb 02, 2019 05:55PM
|
Re: Continued Roth coverage imo points to a Nasdaq listing....
|
5
|
Resverlogix Corp.
|
May 02, 2019 11:58AM
|
Zenith Epigenetics Corp. Announces Name Change & Corporate Reorganization
|
5
|
Zenith Epigenetics
|
Aug 02, 2016 10:36AM
|
Re: Third Eye, AHA, US Listing
|
5
|
Resverlogix Corp.
|
Sep 19, 2019 06:47AM
|
Re: ASN late breaker and CKD sub-study top-line
|
5
|
Resverlogix Corp.
|
Oct 09, 2019 09:20PM
|
Second ZEN003694 Trial now listed on ClinicalTrials.gov
|
5
|
Zenith Epigenetics
|
Mar 20, 2016 09:12PM
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
5
|
Resverlogix Corp.
|
Aug 23, 2019 09:19AM
|
Re: Timelines
|
5
|
Resverlogix Corp.
|
Aug 27, 2019 06:59AM
|
Re: Shrinking MACE event rate
|
5
|
Resverlogix Corp.
|
Jan 21, 2019 11:08AM
|
Resverlogix Corporate Update 4/23/2019
|
5
|
Resverlogix Corp.
|
Apr 23, 2019 10:51PM
|
Re: Did someone already post this?
|
5
|
Resverlogix Corp.
|
Aug 17, 2017 11:47AM
|
Link library cleaned up
|
5
|
Resverlogix Corp.
|
Nov 27, 2017 11:17AM
|
Re: Dr. Kausik Ray will deliver the AHA Late Breaking Presentation on BETonMACE
|
5
|
Resverlogix Corp.
|
Nov 03, 2019 02:02PM
|
Re: About that stroke failure
|
5
|
Resverlogix Corp.
|
Dec 13, 2019 01:35PM
|
Framework for Addressing Residual CVD Risk
|
5
|
Resverlogix Corp.
|
Apr 13, 2018 01:03PM
|
Re: OFF-TOPIC discussion set-up and in progress....
|
5
|
Resverlogix Corp.
|
Oct 26, 2016 10:02AM
|
PCSK9 vaccination
|
5
|
Resverlogix Corp.
|
Jun 22, 2017 12:40PM
|